Vaccine Makers Signal Fear Over Removal of Neurotoxic Injected Aluminum Ingredient
Former FDA head Gottlieb takes to CNBC to warn RFK Jr's newly formed ACIP may target aluminum adjuvants next as they've just done with thimerosal
Former FDA commissioner Dr. Scott Gottlieb made his ceremonial appearance on CNBC to titrate the public well with Big Pharma talking points in the wake of this week’s ACIP meeting.
After speaking for less than one minute and fortty seconds, Gottlieb used the tired, inaccurate slur ‘anti-vaxxer’ four times in a failed attempt to frame an us verse them narrative like it was 2015 again.
With the newly appointed ACIP committee vote to remove the mercury-based preservative thimerosal from the few remaining flu shots, Gottlieb wasted no time circling the wagons to protect the widespread, problematic aluminum adjuvant in several vaccines on the CDC’s childhood schedule.
His concern was that would be ACIP’s next target. And he’s probably right.
“This is a very safe ingredient” stated Gottlieb regarding the regular injection of aluminum nanoparticles into infants, children and adolescents at scale.
Zero pushback or questions from the interviewer to challenge him per usual.
How settled is the safety science of injecting aluminum in children?
The Informed Consent Action Network sent a legal letter to the U.S. Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) in 2019 demanding any human or animal studies relied upon by these agencies to establish the safety of injected aluminum.
The agencies produced no documents nor could they located a single study showing the safety of aluminum in childhood vaccines.
Meanwhile, a 2021 study published in the Journal of Trace Elements in Medicine and Biology found that six childhood vaccines contain a statistically significant greater quantity of aluminum adjuvant than is provided for on these products’ labeling. This study promped ICAN to demand the FDA assure that vaccine manufacturers are disclosing accurate information regarding the amount of aluminum adjuvant in their childhood vaccines. The agency has since stonewalled the request.
Here’s the embarrassing, anti-scientific part Gottlieb forgets to mention.
The rationale for injecting aluminum adjuvant nanoparticles into newborns was allowed and justified by a single 2011 study, by a single FDA scientist named Dr. Robert Mitkus.
Author J.B. Handley in his book How to End the Autism Epidemic writes the following about Mitkus’ study:
What would be lost on the average layperson is that the only biological science Dr. Mitkus considered in making his safety assessment was a single study that infused (rather than injected) aluminum citrate (rather than aluminum hydroxide) into adults (rather than babies). It’s hard to put this seemingly minor detail in proper context. In no other drug on the planet (except for vaccines) would safety standards ever be determined without using the actual product (aluminum hydroxide) administered in the proper way (intramuscular injection), into the proper patient population (infants).
World-renowned researchers called out this fact in their 2018 study by stating:
“To date, aluminum adjuvants per se have, perhaps surprisingly, not been the subject of any official experimental investigation, and this being in spite of the well-established neurotoxicity of aluminum.”
Will aluminum adjuvants be ACIP’s next target? Are studies being commissioned by Jay Bhattacharya’s NIH to look at these ingredients and their well-established role in creating chronic disease in American Children? All open questions at the time of this writing.
As for Scott and his industry pals, shots across the bow appear to be signaling that it’s no longer business as usual.
Gottlieb left his position as FDA commissioner only to accept a position on the board of Pfizer in less than three months.
Gottlieb is Big Pharma’s jack-in-the-box who seems to pop up and make noise at key moments when public pressure is applied which threatens bottom line profit margins of their liability-free injectable product lines.
His corporate media residency at CNBC allows for rapid response industry talkings points to roll from his mouth at a moment’s notice whenever his handlers decide to make him dance.
Prior to the pandemic, as questions swirled about a connection between vaccines and autism, Gottleib was there. When asked by the CNBC reporter why parents claim that their children developed autism or “something on the spectrum” right around the time they received their shots, Gottlieb blamed coincidence by saying:
“Children who are gonna display symptoms of autism and other developmental disorders, those start to manifest and become self-evident right around the time kids are getting vaccinated.”
Magic. Like Fauci, Gottleib is his own version of The Science™. What he says is ordained, never questioned during interviews. A continuous appeal to authority. Why? Because Pfizer man said so.
With a little luck, revolving door riders like Gottlieb will be artifacts of a shameful past era. Where U.S. regulatory agencies continually launched their leaders into the waiting arms of the industries they regulated.
One of my former employers had hired Gottlieb as our “official medical advisor” during the pandemic. It was mostly a PR move to try and assure our passengers that we were “employing the latest and greatest” in limiting the spread of the dreaded COVID virus. How I hated seeing a member of the Board of Pfizer giving out any kind of advice and the media lapdogs all clapping like seals in approval. No one wanted to hear any questions about his obvious conflicts of interests and his soaring stock value which tripled or more at the time. I tried asking such questions during one of our interactive online company discussions. Somehow, my questions never made it on screen. This guy should be sued for malpractice by any and all who listened to him.
Beelzebub hath spoken.